Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
申请人:Kimura Tomio
公开号:US20060128756A1
公开(公告)日:2006-06-15
Compounds having activity against production of an inflammatory cytokine of formula (I)′:
A′ is pyrrole; R
1′
is phenyl or naphthyl; R
2′
is pyridyl or pyrimidinyl; R
3′
is (IIa)′, (IIb)′ or (IIc)′:
m′ is 1; E′ is nitrogen; D′ is >C(R
5′
), R
5′
is hydrogen, Substituent α′ or Substituent β′; B′ is nitrogen-containing 5-membered heterocyclic; R
4′
is 1 to 3 substituents from Substituent α′, Substituent β′ and Substituent γ′; R
1′
and R
3′
are bonded to two atoms of the pyrrole adjacent to the pyrrole atom bonded to R
2′
; Substituent α′ is hydroxyl, nitro, cyano, halogen, alkoxy, halogeno alkoxy, alkylthio, halogeno alkylthio or —NR
a′
R
b′
; R
a′
and R
b′
are hydrogen, alkyl, alkenyl, alkynyl, aralkyl or alkylsulfonyl, or R
a′
and R
b′
with the nitrogen atom form a heterocyclyl; Substituent β′ is alkyl, alkenyl, alkynyl, aralkyl or cycloalkyl; Substituent γ′is oxo, hydroxyimino, alkoxyimino, alkylene, alkylenedioxy, alkylsulfinyl, alkylsulfonyl, aryl, aryloxy, alkylidenyl or aralkylidenyl.
具有对公式(I)'的炎症细胞因子产生活性的化合物:A'为吡咯;R1'为苯基或萘基;R2'为吡啶基或嘧啶基;R3'为(IIa)',(IIb)'或(IIc)';m'为1;E'为氮;D'为>C(R5'),R5'为氢,取代基α'或取代基β';B'为含氮的5元杂环;R4'为取代基α',取代基β'和取代基γ'中的1至3个取代基;R1'和R3'与靠近R2'的吡咯原子相连;取代基α'为羟基,硝基,氰基,卤素,烷氧基,卤代烷氧基,烷基硫基,卤代烷基硫基或-NRa'Rb';Ra'和Rb'为氢,烷基,烯基,炔基,芳基烷基或烷基磺酰基,或Ra'和Rb'与氮原子形成杂环基;取代基β'为烷基,烯基,炔基,芳基烷基或环烷基;取代基γ'为氧代,羟基亚胺基,烷氧基亚胺基,烷基,烷二氧基,烷基亚磺酰基,烷基磺酰基,芳基,芳氧基,烷基亚甲基或芳基亚甲基。